Evidence map›Paper›PMID 15613540›Full record

ArticleRNA (New York, N.Y.)2005

Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs.

Rui Yi, Brian P Doehle, Yi Qin, Ian G Macara, Bryan R Cullen

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 274 citations in OpenAlex.

  1. Review
  2. Small-molecule-based targeted therapy in liver cancer.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review
  3. Article
  4. Review
  5. Optimal delivery of RNA interference by viral vectors for cancer therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Molecular therapy. Nucleic acids · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.International journal of molecular sciences · 2021
    Review
  18. Plant physiology · 2020
    Article
  19. Review
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rui YiDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Box 3025, Room 426 CARL Building, Research Drive, Durham, NC 27710, USA.
Brian P Doehle
Yi Qin
Ian G Macara
Bryan R Cullen
University of Virginia · USDuke University · USHoward Hughes Medical Institute · US

Funding

The RAN GTPaseR01GM050526 · NIGMS · VANDERBILT UNIVERSITY · PI MACARA, IAN G · 1994 to 2014
$4.8M
Regulation of human microRNA biosynthesis and activityR01GM071408 · NIGMS · DUKE UNIVERSITY · PI CULLEN, BRYAN R. · 2004 to 2007
$1.1M
NIGMS NIH HHS R01 GM050526NIGMS NIH HHS R01 GM071408
6 · The paper itself

Abstract

Plasmids or viral vectors that express short hairpin RNAs (shRNAs) have emerged as important tools for the stable inhibition of specific genes by RNA interference. shRNAs are structural and functional homologs of pre-microRNAs, intermediates in the production of endogenously encoded microRNAs (miRNAs). Therefore, overexpressed shRNAs could inhibit miRNA function by competing for a limiting level of one or more factors involved in miRNA biogenesis or function. Here, we demonstrate that overexpressed shRNAs can saturate the activity of endogenous Exportin 5, a factor required for nuclear export of both shRNAs and pre-miRNAs. While shRNA overexpression can therefore inhibit miRNA function, simultaneous overexpression of Exportin 5 reverses this effect. Moreover, Exportin 5 overexpression can significantly enhance RNA interference mediated by shRNAs. These data have implications for the future clinical utilization of shRNAs and also provide a simple method to enhance RNA interference by shRNAs in culture.

Indexed as

RNA InterferenceActive Transport, Cell NucleusAnimalsCell LineCell Line, TumorGene ExpressionHumansKaryopherinsMicroRNAsPlasmidsran GTP-Binding ProteinKaryopherinsMicroRNAsran GTP-Binding ProteinXPO5 protein, human

Identifiers

PMID15613540
PMCPMC1370710
OpenAlexW2101857401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.